Iovance Biotherapeutics shareholders are still up 122 percent over 1 year despite pulling back 7.1 percent in the past week
| IOVA Stock | USD 10.72 0.16 1.47% |
About 61% of Iovance Biotherapeutics' investor base is looking to short. The analysis of overall sentiment of trading Iovance Biotherapeutics stock suggests that many investors are alarmed at this time. Iovance Biotherapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Iovance Biotherapeutics. The current market sentiment, together with Iovance Biotherapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Iovance Biotherapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Iovance Biotherapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Iovance daily returns and investor perception about the current price of Iovance Biotherapeutics as well as its diversification or hedging effects on your existing portfolios.
Iovance |
Unless you borrow money to invest, the potential losses are limited. On the other hand, if you find a high quality...
Read at finance.yahoo.com
 |
Iovance Biotherapeutics Fundamental Analysis
We analyze Iovance Biotherapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Iovance Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Iovance Biotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Iovance Biotherapeutics is currently under evaluation in number of shares shorted category among related companies. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Iovance Biotherapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iovance Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Iovance Biotherapeutics could also be used in its relative valuation, which is a method of valuing Iovance Biotherapeutics by comparing valuation metrics with similar companies.
Peers
Iovance Biotherapeutics Related Equities
| HEPA | Hepion Pharmaceuticals | 6.61 | ||||
| CVAC | CureVac NV | 2.06 | ||||
| SRPT | Sarepta Therapeutics | 0.73 | ||||
| KRYS | Krystal Biotech | 0.04 | ||||
| MDGL | Madrigal Pharmaceuticals | 0.16 | ||||
| OCEA | Ocean Biomedical | 1.30 | ||||
| PTCT | PTC Therapeutics | 1.64 | ||||
| APLS | Apellis Pharmaceuticals | 4.21 |
Check out Iovance Biotherapeutics Hype Analysis, Iovance Biotherapeutics Correlation and Iovance Biotherapeutics Performance. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Iovance Stock analysis
When running Iovance Biotherapeutics' price analysis, check to measure Iovance Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iovance Biotherapeutics is operating at the current time. Most of Iovance Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Iovance Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iovance Biotherapeutics' price. Additionally, you may evaluate how the addition of Iovance Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Iovance Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. If investors know Iovance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iovance Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Iovance Biotherapeutics is measured differently than its book value, which is the value of Iovance that is recorded on the company's balance sheet. Investors also form their own opinion of Iovance Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iovance Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iovance Biotherapeutics' market value can be influenced by many factors that don't directly affect Iovance Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iovance Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.